Life-threatening drug interactions and contraindications

Drug Interactions Quiz for PTCB

Which of the following is a life-threatening interaction between warfarin and aspirin?
Increased risk of bleeding
Decreased anticoagulant effect
Increased risk of hypertension
No significant interaction
Which drug-disease interaction is contraindicated in patients with asthma?
Beta-blockers
ACE inhibitors
Calcium channel blockers
Diuretics
What is the primary concern with combining MAO inhibitors and tyramine-rich foods?
Hypertensive crisis
Hypoglycemia
Increased sedation
Gastrointestinal bleeding
Which of the following is a common drug-drug interaction with grapefruit juice?
Increased absorption of statins
Decreased absorption of antibiotics
Increased metabolism of antihistamines
No significant interaction
Which drug-nutrient interaction can occur with tetracycline and dairy products?
Decreased drug absorption
Increased drug toxicity
Enhanced drug efficacy
No significant interaction
Which of the following is a contraindication for metformin in patients with renal impairment?
Increased risk of lactic acidosis
Increased risk of hypoglycemia
Decreased drug efficacy
No significant interaction
What is the primary concern with combining SSRIs and St. John's Wort?
Serotonin syndrome
Decreased antidepressant effect
Increased sedation
No significant interaction
Which of the following is a drug-laboratory interaction for digoxin?
False elevation of potassium levels
False decrease in sodium levels
False elevation of calcium levels
No significant interaction
Which drug-disease interaction is contraindicated in patients with gout?
Thiazide diuretics
Beta-blockers
ACE inhibitors
Calcium channel blockers
What is the primary concern with combining alcohol and acetaminophen?
Increased risk of liver damage
Decreased analgesic effect
Increased sedation
No significant interaction
Which of the following is a common drug-dietary supplement interaction with ginkgo biloba?
Increased risk of bleeding
Decreased anticoagulant effect
Increased risk of hypertension
No significant interaction
Which drug-nutrient interaction can occur with levothyroxine and calcium supplements?
Decreased drug absorption
Increased drug toxicity
Enhanced drug efficacy
No significant interaction
Which of the following is a contraindication for NSAIDs in patients with peptic ulcer disease?
Increased risk of gastrointestinal bleeding
Decreased analgesic effect
Increased risk of hypertension
No significant interaction
What is the primary concern with combining ACE inhibitors and potassium supplements?
Hyperkalemia
Hypokalemia
Increased risk of hypertension
No significant interaction
Which of the following is a drug-laboratory interaction for heparin?
False elevation of aPTT
False decrease in INR
False elevation of platelet count
No significant interaction

Drug Interactions and Contraindications

Drug interactions and contraindications are critical areas of study for pharmacy professionals, as they directly impact patient safety and therapeutic outcomes. These interactions can occur between drugs, diseases, dietary supplements, laboratory tests, and nutrients. Understanding these interactions helps pharmacists prevent adverse effects, optimize therapy, and provide effective patient counseling. Let’s discuss common and life-threatening interactions and contraindications across various categories.

Drug-Drug Interactions (DDIs)

Drug-drug interactions occur when one drug affects the activity of another drug, leading to altered therapeutic effects or increased toxicity.

Warfarin and Antibiotics

Interaction: Antibiotics like metronidazole and ciprofloxacin can increase the anticoagulant effect of warfarin.
Mechanism: Antibiotics alter gut flora, reducing vitamin K production, and inhibit warfarin metabolism.
Clinical Impact: Increased risk of bleeding.
Management: Monitor INR closely and adjust warfarin dose as needed.

Simvastatin and Amiodarone

Interaction: Amiodarone increases simvastatin levels by inhibiting CYP3A4.
Mechanism: Reduced metabolism of simvastatin.
Clinical Impact: Increased risk of rhabdomyolysis.
Management: Avoid high doses of simvastatin with amiodarone; consider alternative statins.

SSRIs and NSAIDs

Interaction: Combining SSRIs (e.g., fluoxetine) with NSAIDs (e.g., ibuprofen) increases the risk of gastrointestinal bleeding.
Mechanism: Both drugs independently increase bleeding risk.
Clinical Impact: Severe gastrointestinal hemorrhage.
Management: Use gastroprotective agents (e.g., proton pump inhibitors) if co-administration is necessary.

Drug-Disease Interactions

Drug-disease interactions occur when a drug exacerbates a pre-existing medical condition.

NSAIDs and Heart Failure

Interaction: NSAIDs can worsen heart failure by causing fluid retention and reducing the efficacy of diuretics.
Mechanism: NSAIDs inhibit prostaglandins, leading to sodium and water retention.
Clinical Impact: Exacerbation of heart failure symptoms.
Management: Avoid NSAIDs in heart failure patients; use acetaminophen for pain relief.

Beta-Blockers and Asthma

Interaction: Non-selective beta-blockers (e.g., propranolol) can trigger bronchospasm in asthma patients.
Mechanism: Blockade of beta-2 receptors in the lungs.
Clinical Impact: Severe asthma exacerbation.
Management: Use cardioselective beta-blockers (e.g., metoprolol) with caution.

Metformin and Renal Impairment

Interaction: Metformin can accumulate in patients with renal impairment, increasing the risk of lactic acidosis.
Mechanism: Reduced renal excretion of metformin.
Clinical Impact: Life-threatening lactic acidosis.
Management: Avoid metformin in patients with eGFR < 30 mL/min.

Drug-Dietary Supplement Interactions

Dietary supplements can interact with medications, altering their efficacy or safety.

St. John’s Wort and Antidepressants

Interaction: St. John’s Wort induces CYP3A4 and P-glycoprotein, reducing the levels of SSRIs and other antidepressants.
Mechanism: Increased metabolism and efflux of antidepressants.
Clinical Impact: Reduced antidepressant efficacy.
Management: Avoid concurrent use; educate patients about potential interactions.

Ginkgo Biloba and Anticoagulants

Interaction: Ginkgo biloba can increase the risk of bleeding when taken with anticoagulants like warfarin.
Mechanism: Ginkgo has antiplatelet properties.
Clinical Impact: Increased bleeding risk.
Management: Monitor INR closely and advise patients to avoid ginkgo.

Calcium Supplements and Thyroid Medications

Interaction: Calcium supplements can reduce the absorption of levothyroxine.
Mechanism: Calcium binds to levothyroxine in the gastrointestinal tract.
Clinical Impact: Reduced thyroid hormone levels.
Management: Administer levothyroxine on an empty stomach and separate calcium intake by at least 4 hours.

Drug-Laboratory Interactions

Drugs can interfere with laboratory tests, leading to inaccurate results.

Proton Pump Inhibitors (PPIs) and Vitamin B12 Levels

Interaction: Long-term PPI use can lead to falsely low vitamin B12 levels.
Mechanism: PPIs reduce gastric acid, impairing vitamin B12 absorption.
Clinical Impact: Misdiagnosis of vitamin B12 deficiency.
Management: Monitor vitamin B12 levels in patients on long-term PPI therapy.

Acetaminophen and Liver Function Tests

Interaction: High doses of acetaminophen can elevate liver enzymes (ALT, AST).
Mechanism: Hepatotoxicity due to metabolite accumulation.
Clinical Impact: False indication of liver damage.
Management: Avoid excessive acetaminophen use; monitor liver function tests.

Biotin and Thyroid Function Tests

Interaction: High doses of biotin can interfere with thyroid function tests.
Mechanism: Biotin binds to assay reagents, causing false results.
Clinical Impact: Misdiagnosis of thyroid disorders.
Management: Discontinue biotin 48 hours before thyroid testing.

Drug-Nutrient Interactions

Drugs can interact with nutrients, affecting their absorption or metabolism.

Tetracyclines and Dairy Products

Interaction: Calcium in dairy products binds to tetracyclines, reducing their absorption.
Mechanism: Formation of insoluble complexes.
Clinical Impact: Reduced antibiotic efficacy.
Management: Advise patients to avoid dairy products 2 hours before and after taking tetracyclines.

Warfarin and Vitamin K-Rich Foods

Interaction: Foods high in vitamin K (e.g., leafy greens) can reduce the anticoagulant effect of warfarin.
Mechanism: Vitamin K antagonizes warfarin’s mechanism of action.
Clinical Impact: Reduced anticoagulation efficacy.
Management: Maintain a consistent vitamin K intake and monitor INR regularly.

ACE Inhibitors and Potassium-Rich Foods

Interaction: ACE inhibitors (e.g., lisinopril) can cause hyperkalemia when combined with potassium-rich foods (e.g., bananas, oranges).
Mechanism: ACE inhibitors reduce potassium excretion.
Clinical Impact: Risk of hyperkalemia and cardiac arrhythmias.
Management: Monitor serum potassium levels and advise patients to limit high-potassium foods.

Welcome, pharmacy Professionals! Explore Questions, Essential Drug knowledge, Questionnaire, Quiz & Pharmacy settings insights to excel in your studies.

About

Quick links

Our Newsletter

Got Questions? Call us